The Rosen Law Firm, P.A. Announces Proposed Class Action

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
The Rosen Law Firm, P.A. Announces Proposed Class Action Settlement on Behalf of Purchasers of Common Stock of Radient Pharmaceuticals Corporation -- RXPC

SANTA ANA, Calif., Feb. 12, 2014 (GLOBE NEWSWIRE) -- The Rosen Law Firm, P.A. announces that the United States District Court Central District of California Southern Division has approved the following announcement of a proposed class action settlement that would benefit purchasers of common stock of Radient Pharmaceuticals Corporation (OTCMKTS:RXPC):

SUMMARY NOTICE OF CLASS ACTION SETTLEMENT

TO: ALL PERSONS WHO PURCHASED OR OTHERWISE ACQUIRED ANY COMMON STOCK OF RADIENT PHARMACEUTICALS CORPORATION DURING THE PERIOD FROM JANUARY 18, 2011 THROUGH MARCH 4, 2011, INCLUSIVE.

YOU ARE HEREBY NOTIFIED, pursuant to an Order of the United States District Court for the Central District of California, that a hearing will be held on April 22, 2014 at 8:30 a.m. before the Honorable David O. Carter, United States District Judge of the Central District of California, 411 West Fourth Street, Santa Ana, California 92701 (the "Settlement Hearing") for the purpose of determining: (1) whether the proposed Settlement consisting of the sum of $2,500,000 should be approved by the Court as fair, reasonable, and adequate; (2) whether the proposed plan to distribute the settlement proceeds is fair, reasonable, and adequate; (3) whether the application for an award of attorneys' fees of $750,000 or 30.0% and reimbursement of expenses of not more than $480,000, and an incentive payment of no more than $9,000 to lead plaintiffs, should be approved; and (4) whether the Litigation should be dismissed with prejudice.

If you purchased common stock of Radient Pharmaceuticals Corporation, during the period between January 18, 2011 and March 4, 2011, inclusive, your rights may be affected by the Settlement of this action. If you have not received a detailed Notice of Pendency and Settlement of Class Action and a copy of the Proof of Claim and Release, you may obtain copies by writing to Radient Pharmaceuticals Corporation Litigation, c/o Strategic Claims Services, P.O. Box 230, 600 N. Jackson St., Ste. 3, Media, PA 19063; calling 866-274-4004; faxing 610-565-7985; emailing info@strategicclaims.net ; or going to the website, www.strategicclaims.net . If you are a member of the Class, in order to share in the distribution of the Net Settlement Fund, you must submit a Proof of Claim and Release postmarked no later than April 16, 2014, establishing that you are entitled to recovery. Unless you submit a written exclusion request, you will be bound by any judgment rendered in the Litigation whether or not you make a claim. If you desire to be excluded from the Class, you must submit a request for exclusion so that it is received no later than March 24, 2014, in the manner and form explained in the detailed Notice to the Claims Administrator.

Any objection to the Settlement, Plan of Allocation, or the Lead Counsel's request for an award of attorneys' fees and reimbursement of expenses must be in the manner and form explained in the detailed Notice and received no later than April 2, 2014, to each of the following:

     
Clerk of the Court Laurence M. Rosen, Esq. Robert Weber, Esq.
United States District Court Phillip Kim, Esq. DLA PIPER (US) LLP
Central District of California - Southern Division THE ROSEN LAW FIRM, P.A. 2000 Avenue of the Stars
411 West Fourth Street 275 Madison Avenue, 34 th Floor Suite 400, North Tower
Santa Ana, California 92701 New York, New York 10016 Los Angeles, California 90067
  Tel.: 212-686-1060 Tel: 310-595-3000
  Fax: 212-202-3827 Fax: 310-595-3300
     
  Lead Counsel Counsel for defendant Radient Pharmaceuticals Corporation
     
    Mark David Hunter, Esq.
    HUNTER TAUBMAN WEISS LLP
    255 University Drive
    Coral Gables, Florida 33134
    Tel: 305-629-8816
    Fax: 305-629-8877
    Counsel for defendant 
    Douglas MacLellan
     

If you have any questions about the Settlement, you may call or write to Lead Counsel:

Laurence M. Rosen, Esq.
Phillip Kim, Esq.
THE ROSEN LAW FIRM, P.A.
275 Madison Avenue, 34 th Floor
New York, New York 10016
Tel.: 212-686-1060 
Fax: 212-202-3827

PLEASE DO NOT CONTACT THE COURT OR THE CLERK'S OFFICE REGARDING THIS NOTICE.

DATED: JANUARY 31, 2014

BY ORDER OF THE UNITED STATES
DISTRICT COURT FOR THE CENTRAL
DISTRICT OF CALIFORNIA

Scroll down for more posts ▼

Top 10 Most Recent News Articles

HERVolution's HERV-K Antigens: A Cancer Breakthrough?

Updated Category News Views 120

Digging into HERVolution's Game-Changing Data Picture HERVolution in the spotlight, rolling out data that could shake up our approach to cancer immunotherapy. The big headline? HERV-K antigens might just be the whistle-blower we've been looking for to get the immune system off the bench and onto the field. How's that for a kick in the conventional wisdom of cancer...

Continue Reading
DAR Logs Massive 587,000 Service Hours Nationwide

Updated Category News Views 92

A Month of Patriotism and Service You've got to hand it to the Daughters of the American Revolution (DAR)—when they commit, they go all in. This year, they turned their usual Day of Service into a full-blown Month of Service, packing in over 587,000 hours of volunteering nationwide. From historic spots to food pantries, DAR members showed up, and honestly, it's the kind...

Continue Reading
Landis+Gyr's Q2 Gains and Future Strategies

Updated Category News Views 0

Landis+Gyr's Multi-Faceted Financial Leap In the unpredictable landscape of energy tech, Landis+Gyr has thrown down some noteworthy cards in their latest financial disclosures. We're talking a Q2 net revenue sitting pretty at $269.2 million, and it's no mistake they landed a record-smashing adjusted gross margin of 38.0%. All this while wrangling an order intake of $170.3...

Continue Reading
Casio's CMK?100: A Lightweight Marvel Blending Style and Utility

Updated Category News Views 77

A Timepiece That Redefines Everyday Elegance There's a new player in the vast realm of watches, and it's got tongues wagging: the Casio CMK?100. You don’t see that blend of style, comfort, and practicality grow on trees, my friend. Casio’s new offering, the CMK?100, wears its purpose on its titanium sleeve: lightweight and stylish, it’s a suave addition to any wrist...

Continue Reading
Yale's $10M Inflammation Initiative: Future Health Impact

Updated Category News Views 25

Yale’s Inflammation Research: Beyond the Basics Inflammation. It’s the kind of battle your own body wages from within, and Yale School of Medicine’s fresh $10 million grant from the Blavatnik Family Foundation means they’re marching deeper into the trenches. This is not another academic exercise; it’s about digging out the roots of diseases that are tough to pin...

Continue Reading
MPLX Adds Industry Veterans to Board Leadership

Updated Category News Views 38

A New Era for MPLX's Board Nothing shakes up the scene like announcing two heavyweights joining the board, and that's exactly what MPLX LP (NYSE: MPLX) just pulled off. Micheal G. Dunn and Bruce L. Niemeyer are coming onboard, effective November 1, 2026. With pedigrees that could make any industry insider nod in approval, these guys bring decades of experience to the...

Continue Reading
7-Eleven Rolls Out Korean Flavors in Bold Menu Shift

Updated Category News Views 155

7-Eleven's New Global Menu Twist October 2026 sees 7-Eleven, Inc. whip out an intriguing move, venturing east with its new Flavors of Korea menu. They're not just changing the game in convenience store aisles; they're dancing to the beat of global flavors—a shake-up fit for the world's largest convenience retailer. Think about bodega basics getting a spicy Korean...

Continue Reading
From Missouri to Market: A New Spin on Turkey Calls

Updated Category News Views 24

Innovating the Turkey Call Game You want innovation? Well, wrap your head around this: a Missouri inventor is flipping the script on turkey mouth calls. The goal? To ditch the wrinkles and make turkey hunting that much smoother. It might seem a bit niche, but when you've been around long enough, you know these 'niche' ideas can sometimes hatch golden eggs for investors....

Continue Reading
Bechtel's $1M Push for Wyoming's Skilled Trades Future

Updated Category News Views 204

Wyoming's Bid for Skilled Trades Revolution You’d think with all the talk about tech and white-collar jobs, we’ve forgotten the backbone that keeps the world ticking—skilled trades. Turns out, Bechtel hasn’t. The company just tossed a cool million at Wyoming's Laramie County Community College and Western Wyoming College. What’s that doing? It's jumpstarting...

Continue Reading
Trump Quotation Book Takes Unbiased Approach

Updated Category News Views 0

In the ever-evolving dance of political discourse, a new book strides onto the stage: Not My President, published by Palmetto Publishing. It’s a bold compilation of presidential utterances, capturing the words of Donald J. Trump in all their unvarnished glory. Stripped of analysis or comedic flair, each entry stands alone like a solitary figure at a cocktail party,...

Continue Reading

Top 5 Most Recently Viewed Articles

Empowering Tomorrow's Healers: Dr. Zarkadas' Scholarship

Updated Category News Views 116

Empowering Future Medical Leaders The Dr. Konstantinos Zarkadas Scholarship for Future Doctors is now open for applications. This scholarship invites undergraduate students committed to the field of medicine to apply for a prestigious award. The scholarship, which amounts to a one-time award of $1,000, aims to assist a deserving student who exemplifies both academic...

Continue Reading
Pharma Two B and Hepion Pharmaceuticals Merge for Growth

Updated Category News Views 47

Pharma Two B and Hepion Pharmaceuticals Announce Merger KIRYAT ONO, ISRAEL and EDISON, N.J. — Pharma Two B Ltd., a leading late-stage pharmaceutical company focused on treating Parkinson’s Disease, has officially announced its merger with Hepion Pharmaceuticals, Inc. (Nasdaq: HEPA), which specializes in addressing chronic liver diseases. They have filed a registration...

Continue Reading
Applied Graphite Technologies Grants Stock Options to Team

Updated Category News Views 186

Applied Graphite Technologies' Recent Developments Applied Graphite Technologies Corporation (AGT) has made significant strides in its operations recently by granting 2,350,000 stock options to its consultants, directors, and officers. These options are set at an exercise price of $0.07, and they come with a five-year term, expiring on August 13, 2030. This move...

Continue Reading
Jefferson Solutions Group Sets Course for Strategic Growth

Updated Category News Views 7

Jefferson's Big Move: A Strategic Overhaul The winds of change are blowing over at Jefferson Solutions Group. This May, the company announced a heavy-duty strategic reorganization to better align with its astronomical ambitions for long-term growth. If you're the type that's got a soft spot for high-impact solutions and government gigs, pay attention, because this shift...

Continue Reading
Unbeatable Security Solutions for Your Home This Summer

Updated Category News Views 191

Unbeatable Security Solutions for Your Home This Summer As summer vacation approaches, ensuring the safety of your home becomes vital. Reolink, known for its innovative solutions in visual technology, has announced early Prime Day deals that will make securing your property both convenient and affordable. With these impressive offers, you can invest in top-rated security...

Continue Reading